373 related articles for article (PubMed ID: 15114888)
21. The molecular epidemiology of Stenotrophomonas maltophilia bacteraemia in a tertiary referral hospital in the United Arab Emirates 2000-2004.
Jumaa PA; Sonnevend A; Pàl T; El Hag M; Amith R; Trad O
Ann Clin Microbiol Antimicrob; 2006 Dec; 5():32. PubMed ID: 17194302
[TBL] [Abstract][Full Text] [Related]
22. Stenotrophomonas (Xanthomonas) maltophilia as an emerging opportunistic pathogen in association with HIV infection: a 10-year surveillance study.
Calza L; Manfredi R; Chiodo F
Infection; 2003 Jun; 31(3):155-61. PubMed ID: 12789473
[TBL] [Abstract][Full Text] [Related]
23. Stenotrophomonas maltophilia and antibiotic use in German intensive care units: data from Project SARI (Surveillance of Antimicrobial Use and Antimicrobial Resistance in German Intensive Care Units).
Meyer E; Schwab F; Gastmeier P; Rueden H; Daschner FD; Jonas D
J Hosp Infect; 2006 Nov; 64(3):238-43. PubMed ID: 16979794
[TBL] [Abstract][Full Text] [Related]
24. Stenotrophomonas maltophilia bacteremia in burn patients.
Tsai WP; Chen CL; Ko WC; Pan SC
Burns; 2006 Mar; 32(2):155-8. PubMed ID: 16448762
[TBL] [Abstract][Full Text] [Related]
25. Which patient is a candidate for empirical therapy against Stenotrophomonas maltophilia bacteraemia? An analysis of associated risk factors in a tertiary care hospital.
Metan G; Hayran M; Hascelik G; Uzun O
Scand J Infect Dis; 2006; 38(6-7):527-31. PubMed ID: 16798705
[TBL] [Abstract][Full Text] [Related]
26. A meningitis case due to Stenotrophomonas maltophilia and review of the literature.
Yemisen M; Mete B; Tunali Y; Yentur E; Ozturk R
Int J Infect Dis; 2008 Nov; 12(6):e125-7. PubMed ID: 18579427
[TBL] [Abstract][Full Text] [Related]
27. Molecular typing of clinical isolates of Stenotrophomonas maltophilia by pulsed-field gel electrophoresis and random primer PCR fingerprinting.
Schaumann R; Laurin F; Rodloff AC
Int J Hyg Environ Health; 2008 Jul; 211(3-4):292-8. PubMed ID: 17980662
[TBL] [Abstract][Full Text] [Related]
28. Acquisition and spread of Acinetobacter baumannii and Stenotrophomonas maltophilia in intensive care patients.
Barchitta M; Cipresso R; Giaquinta L; Romeo MA; Denaro C; Pennisi C; Agodi A
Int J Hyg Environ Health; 2009 May; 212(3):330-7. PubMed ID: 18771951
[TBL] [Abstract][Full Text] [Related]
29. Bloodstream infections caused by Stenotrophomonas maltophilia: a seven-year review.
Garazi M; Singer C; Tai J; Ginocchio CC
J Hosp Infect; 2012 Jun; 81(2):114-8. PubMed ID: 22494851
[TBL] [Abstract][Full Text] [Related]
30. [Study on molecular epidemiology of Stenotrophomonas maltophilia in intensive care units].
Yue W; Huang S; Nie S
Zhonghua Jie He He Hu Xi Za Zhi; 2001 Nov; 24(11):651-4. PubMed ID: 16136901
[TBL] [Abstract][Full Text] [Related]
31. Stenotrophomonas (Xanthomonas) maltophilia: a multidrug-resistant nosocomial pathogen.
Penzak SR; Abate BJ
Pharmacotherapy; 1997; 17(2):293-301. PubMed ID: 9085321
[TBL] [Abstract][Full Text] [Related]
32. [A case-control study on the risk factors for lower respiratory tract infection by Stenotrophomonas maltophilia in a medical intensive care unit].
Xu NL; Shi SJ; Lai ZS; Li HR; Lian SQ; Chen YS
Zhonghua Jie He He Hu Xi Za Zhi; 2011 Oct; 34(10):735-8. PubMed ID: 22321705
[TBL] [Abstract][Full Text] [Related]
33. Stenotrophomonas maltophilia pneumonia in a premature infant.
Ozkan H; Paşaoğlu G; Olgaç N; Günel R; Yüce A; Gülay Z
Turk J Pediatr; 1999; 41(2):283-6. PubMed ID: 10770672
[TBL] [Abstract][Full Text] [Related]
34. Epidemiology of multi-drug-resistant gram-negative bacteria: data from an university hospital over a 36-month period.
Vonberg RP; Wolter A; Chaberny IF; Kola A; Ziesing S; Suerbaum S; Gastmeier P
Int J Hyg Environ Health; 2008 Jul; 211(3-4):251-7. PubMed ID: 17980660
[TBL] [Abstract][Full Text] [Related]
35. Stenotrophomonas maltophilia as a nosocomial pathogen.
Köseoğlu O; Sener B; Gülmez D; Altun B; Gür D
New Microbiol; 2004 Jul; 27(3):273-9. PubMed ID: 15460530
[TBL] [Abstract][Full Text] [Related]
36. [Infections caused by Stenotrophomonas maltophilia (SMA) in intensive care patients--a prospective case-control study].
Raffenberg M; Szymanski T; Lubasch A; Erbes R; Wagner S; Weist K; Mansmann U; Lode H
Dtsch Med Wochenschr; 2001 May; 126(18):514-8. PubMed ID: 11381633
[TBL] [Abstract][Full Text] [Related]
37. Nosocomial infections among pediatric hematology/oncology patients: results of a prospective incidence study.
Urrea M; Rives S; Cruz O; Navarro A; García JJ; Estella J
Am J Infect Control; 2004 Jun; 32(4):205-8. PubMed ID: 15175614
[TBL] [Abstract][Full Text] [Related]
38. Stenotrophomonas maltophilia: the significance and role as a nosocomial pathogen.
Senol E
J Hosp Infect; 2004 May; 57(1):1-7. PubMed ID: 15142709
[TBL] [Abstract][Full Text] [Related]
39. [Stenotrophomonas maltophilia as a cause of hospital infections--typing of clinical isolates using pulsed field gel electrophoresis] ].
Tripković V; Müller-Premru M; Kalenić S; Plecko V; Jelić I; Filipović-Grcić B; Jandrlić M
Lijec Vjesn; 2001; 123(9-10):237-41. PubMed ID: 11845578
[TBL] [Abstract][Full Text] [Related]
40. Risk factors and clinical characteristics of Stenotrophomonas maltophilia infections in neonates.
Mutlu M; Yılmaz G; Aslan Y; Bayramoğlu G
J Microbiol Immunol Infect; 2011 Dec; 44(6):467-72. PubMed ID: 21606009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
